More about: Irinotecan-related cholinergic syndrome induced by coadministration of oxaliplatin [5]

Journal of the National Cancer Institute

Volumn 91, Issue 1, 1999, Pages 91-92

  Dodds, H M ^a   Bishop, J F ^a   Rivory, L P ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ACETYLCHOLINESTERASE; ATROPINE; CISPLATIN; CYCLOPHOSPHAMIDE; IRINOTECAN; OXALIPLATIN;

ABDOMINAL PAIN; CANCER; CANCER COMBINATION CHEMOTHERAPY; CHOLINESTERASE INHIBITION; CLINICAL TRIAL; DRUG POTENTIATION; DRUG SAFETY; HUMAN; HYPERSALIVATION; LETTER; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0033528095     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.1.91a     Document Type: Letter

References (7)